COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

CLINAM, October 25-28, 2020

UPDATE--The CLINAM meeting originally planned for May 17-20, 2020 has been rescheduled due to the rapidly evolving COVID-19 situation. The new meeting dates are October 25-28, 2020. Details will be updated as they become available. 



Laboratory co-Director and Head of NCL’s Immunology Section, Dr. Marina Dobrovolskaia, will be co-chairing a session with Dr. Janos Szebeni, Semmelweis University, on “Immune Modulation by Nanomedicines: New Therapeutic Approaches, Adverse Phenomena and Safety Testing”. Additionally, Marina will be speaking in the session on “Emerging Biomarkers of Nanoparticle Immunotoxicity: an Outlook in Future.”

Access the preliminary CLINAM 2020 agenda here: https://clinam.org/images/clinam2020/OCTOBER_CLINAM_20_EARLY15.8..pdf